首頁 > 市場調查報告書 > 製藥

眼科藥物

市場調查報告書

商品編碼

1169121

眼部炎症治療市場：按藥物類別、配方、分銷渠道、地區劃分——規模、份額、展望、機會分析，2022-2030 年

Eye Inflammation Treatment Market, by Drug Class, by Dosage Form, by Distribution Channels,, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年11月18日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

眼睛炎症，也稱為眼部炎症，是一種以眼睛的一個或多個區域腫脹為特徵的疾病，可由輕微刺激到某些疾病引起。有。眼睛炎症按受影響的眼睛部分分類。分類包括鞏膜炎、前葡萄膜炎、中間葡萄膜炎、後葡萄膜炎和全葡萄膜炎。全葡萄膜炎是影響整個眼球的炎症的總稱。

眼睛發炎是由多種因素引起的，包括炎症性疾病、眼睛損傷、微生物感染如病毒、細菌和真菌感染，以及接觸某些有害化學物質如強酸和殺蟲劑。 .

市場動態

在預測期內，自身免疫性疾病患病率上升預計也將促進全球眼部炎症治療市場的增長。例如，根據美國國家多發性硬化症協會於 2019 年 2 月在《神經病學》雜誌上發表的一項研究，2017 年美國有近 100 萬成年人患有多發性硬化症。多發性硬化症是一種在炎症和視神經炎的情況下對視神經造成損害的疾病。視神經炎是多發性硬化症的早期症狀。視神經炎會導致一隻眼睛出現眼痛和視力喪失等症狀。類固醇被用作抑制視神經炎症的藥物，有望帶動全球眼部炎症市場。

此外，在預測期內，眼病的先進療法有望推動全球眼部炎症療法市場的增長。例如，根據美國眼科學會 2021 年 11 月 4 日發布的數據，新的干眼症治療方法可能比現有的更有效。眼病的現代治療方法包括改變生活方式、噴鼻劑、鼻塞、消炎藥、深層沖洗裝置和專用隱形眼鏡。美國食品和藥物管理局目前批准的干眼症藥物有 Tirubaya、Restasis、Seaca、Cidra 和 Iceuvis。

這項研究的主要特點

本報告對全球眼部炎症治療市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。我是這裡。
它揭示了不同細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
它還提供關鍵見解，例如市場驅動因素、制約因素、機會、新產品發布或批准、區域前景以及主要參與者採用的競爭戰略。
根據公司概況、業績、產品組合、地域分佈、分銷策略、主要發展和策略以及未來計劃等參數，對全球眼部炎症治療藥物市場的主要參與者進行了概況分析。
本研究涵蓋的主要公司包括 GSK plc.、Alcon Laboratories Inc.、Merck & Co. Inc.、Alimera Sciences, Inc.、AbbVie Inc.、Teva Pharmaceutical Industries Ltd.、Akron Pharma Inc.、Intas Pharmaceuticals Ltd.、Amgen Inc.、Sanofi S.A.、Johnson & Johnson Services Inc.、Pfizer Inc.、Macleods Pharmaceuticals Ltd.、Mylan N.V.、Bausch Health Companies Inc.
這份報告中的見解將使企業營銷人員和高管能夠就未來的產品發布、技術升級、市場擴張和營銷策略做出明智的決策。我猜。
《全球眼部炎症治療藥物市場》報告面向該行業的各種利益相關者，包括投資者、供應商、製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球眼部炎症治療市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第 2 章市場概述

報告內容
- 市場定義和範圍
執行摘要
- 市場細分：按藥物類別
- 市場細分：按劑型
- 市場細分：按分銷渠道
- 按地區劃分的市場細分
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 市場機會
影響分析
監管場景
害蟲分析
最近的產品發布/批准
流行病學
併購

第 4 章全球眼部炎症藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響

對供應鏈的影響
對研發的影響
政府舉措

第 5 章全球眼部炎症藥物市場：按藥物類別，2017-2030

單克隆抗體
抗生素
皮質類固醇
抗病毒劑
抗真菌劑
其他（止痛藥等）

第 6 章全球眼部炎症藥物市場：按配方分類，2017-2030

眼藥水
藥丸
膠囊
其他（眼藥膏等）

第 7 章全球眼部炎症治療市場：按分銷渠道，2017-2030

醫院藥房
零售藥房
在線藥店

第 8 章全球眼部炎症藥物市場，按地區劃分，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
德國
英國
法國
意大利
西班牙
俄羅斯
其他歐洲地區
亞太地區
中國
印度
日本
澳大利亞
韓國
東盟
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
南非
中非
北非

第9章競爭格局

公司簡介
- GSK plc.
- Alcon Laboratories Inc.
- Merck & Co. Inc.
- Alimera Sciences, Inc.,
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd.
- Akron Pharma Inc
- Intas Pharmaceuticals Ltd
- Amgen Inc.
- Sanofi S.A.
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Macleods Pharmaceuticals Ltd.
- Mylan N.V.
- Bausch Health Companies Inc.

第 10 章

參考資料
調查方法

簡介目錄

Product Code: CMI5362

Eye inflammation, also known as ocular inflammation, is a disorder marked by the swelling of one or more eye regions and can be brought on by a number of different things, from minor irritation to specific illnesses. Eye Inflammation is classified according to the part of the eye that has been affected. Scleritis, Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, and Panuveitis are the different classifications. Panuveitis is a general word for an inflammation that affects the entire eye.

Eye inflammation is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides.

Market Dynamics

Increasing prevalence of autoimmune disorders is also expected to benefit in growth of the global eye inflammation treatment market, over the forecast period. For instance, according to a study published in February 2019 by National Multiple Sclerosis Society, in the journal Neurology, in 2017, nearly 1 million adults were living with multiple sclerosis in the U.S. Multiple sclerosis is a disease that reasons inflammation and damage to the optic nerve that cases optic neuritis. Optic neuritis as an early sign of multiple sclerosis. Optic neuritis causes pain in eye, vision loss in one eye, etc. Steroid are used as a medication to reduce inflammation in the optic nerve, which is expected to drive the global eye inflammation market.

Moreover, advanced treatment of eye disease is expected to propel the growth of global eye inflammation treatment market, over the forecast period. For instance, according to data published on November 04, 2021, by American Academy of Ophthalmology, new dry eye treatments may be more effective than existing ones. Modern treatments for eye disease include lifestyle changes, a nasal spray, punctual plugs, anti-inflammatory medications, deep-cleaning devices, and specialized contact lenses. Currently available medications for the treatment of dry eye disease, approved by the U.S. Food and Drug Administration are Tyrvaya, Restasis, Cequa, Xiidra and Eysuvis.

Key features of the study:

This report provides an in-depth analysis of the global eye inflammation treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global eye inflammation treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include GSK plc., Alcon Laboratories Inc., Merck & Co. Inc., Alimera Sciences, Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Akron Pharma Inc., Intas Pharmaceuticals Ltd., Amgen Inc., Sanofi S.A., Johnson & Johnson Services Inc., Pfizer Inc., Macleods Pharmaceuticals Ltd., Mylan N.V., Bausch Health Companies Inc.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global eye inflammation treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye inflammation treatment market

Detailed Segmentation:

Global Eye Inflammation Treatment Market, By Drug Class:
- Monoclonal Antibodies
- Antibiotics
- Corticosteroids
- Antivirals
- Antifungal
- Others (Analgesics, etc.)
Global Eye Inflammation Treatment Market, By Dosage Form:
- Eye Drops
- Tablets
- Capsules
- Others (Ophthalmic Ointments, etc.)
Global Eye Inflammation Treatment Market, By Distribution Channels:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Eye Inflammation Treatment Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis AG *
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Alcon Laboratories Inc.
- Merck & Co. Inc.
- Alimera Sciences, Inc.,
- AbbVie Inc
- Teva Pharmaceutical Industries Ltd.
- Akron Pharma Inc
- Intas Pharmaceuticals Ltd
- Amgen Inc.
- Sanofi S.A.
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Macleods Pharmaceuticals Ltd.
- Mylan N.V.
- Bausch Health Companies Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channels
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Eye Inflammation Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

Impact on Supply Chain
Impact on Research and Development
Government Initiatives

5. Global Eye Inflammation Treatment Market, By Drug Class, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Antifungal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others (Analgesics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

6. Global Eye Inflammation Treatment Market, By Dosage Form, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Others (Ophthalmic Ointments, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

7. Global Eye Inflammation Treatment Market, By Distribution Channels, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Eye Inflammation Treatment Market, By Region, 2017 - 2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2030
- Regional Trends
North America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Drug Class, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Dosage Form, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channels, 2017 - 2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
South Africa
Central Africa
North Africa